Formoterol / Glycopyrrolate Dosage
Medically reviewed on December 26, 2017.
Applies to the following strengths: 4.8 mcg-9 mcg/inh
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance
2 inhalations orally twice a day, in the morning and in the evening
Maximum dose: 2 inhalations twice daily
-Two inhalations of formoterol 4.8 mcg-glycopyrrolate 9 mcg equal one dose.
Uses: Long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema
Renal Dose Adjustments
No adjustment recommended.
Liver Dose Adjustments
No adjustment recommended.
US BOXED WARNING(S):
Asthma -Related Death:
Long-acting beta2-adrenergic agonists (LABAs) increase the risk of asthma-related death. Data from a large placebo-controlled US trial that compared the safety of another LABA (salmeterol) with placebo added to usual asthma therapy showed an increase in asthma-related deaths in subjects receiving salmeterol. This finding with salmeterol is considered a class effect of all LABAs, including formoterol fumarate, one of the active ingredients in this combination drug.
The safety and efficacy of this combination drug in patients with asthma have not been established and it is not indicated for the treatment of asthma.
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Data not available
-For oral inhalation only.
-Priming the inhalation device before using for the first time to ensure appropriate drug content in each actuation. The manufacturer product information should be consulted for additional instructions for its use.
-Shake well before using.
-If a dose is missed, take the next dose at the usual time.
-Do not use more often or more puffs than prescribed.
-Store at controlled room temperature 20C to 25C (68F to 77F)
-The canister should be at room temperature before use
Limitations of use:
-This drug is not indicated for the relief of acute bronchospasm or for the treatment of asthma.
-Patients should read the medication guide and instructions for the use of this drug.
-A rescue inhaler should be provided to patients to treat acute symptoms. Patients should be instructed on how to use the rescue inhaler.
-Seek medical attention immediately if symptoms get worse, or if more inhalations than usual of their rescue inhaler are needed.
-Therapy should not be stopped without physician/provider guidance since symptoms may recur after discontinuation.
-Discontinue previous regular use of short acting beta2-agonist and use them only for the symptomatic relief of acute symptoms.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about formoterol/glycopyrrolate
- Formoterol/glycopyrrolate Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 2 Reviews
- Drug class: bronchodilator combinations
- Formoterol and glycopyrrolate
- Glycopyrrolate and Formoterol
- Glycopyrrolate and formoterol Inhalation (Advanced Reading)
Other brands: Bevespi Aerosphere